Outcomes in Ixekizumab Patients Following Exposure to Secukinumab and Other Biologics in the CorEvitas Psoriasis Registry

INTRODUCTION: The aim of this work is to describe real-world biologic-experienced psoriasis patients initiating ixekizumab by prior biologic therapy status and compare the effectiveness of ixekizumab between patients who previously failed secukinumab and those who failed other biologics. We hypothes...

Descripción completa

Detalles Bibliográficos
Autores principales: Lockshin, Benjamin, Harrison, Ryan W., McLean, Robert R., Crabtree, Margaux M., Konicek, Bruce W., Zhu, Baojin, Malatestinic, William N., Atiya, Bilal, Murage, Mwangi J., Burge, Russel T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674822/
https://www.ncbi.nlm.nih.gov/pubmed/36331713
http://dx.doi.org/10.1007/s13555-022-00834-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674822/
https://www.ncbi.nlm.nih.gov/pubmed/36331713
http://dx.doi.org/10.1007/s13555-022-00834-7

Ejemplares similares